In this “Your Stories” podcast from Conquer Cancer, the ASCO Foundation, Dr. Nizar Tannir and Dr. Pavlos Msaouel discuss filling the need for research on rare cancers.

Some recent FDA approvals have made many people aware of tumor-agnostic treatments. But what does that mean and how could it benefit someone with cancer? ASCO Chief Medical Officer Richard L. Schilsky gives insight into this new way of thinking about cancer treatment.